Skip to main content

Table 2 Factors influencing long-term survival after resection in 135 patients with gallbladder cancer

From: Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes

Variable

Number of patients

Survival rate (%)

Univariate analysis

Multivariate analysis

  

5-year

10-year

P value

Relative risk (95% CI)

P value

Age (years)

   

0.123

  

≤70

86

66

63

   

>70

49

52

49

   

Sex

   

0.652

  

Male

41

66

61

   

Female

94

59

57

   

Gallstone

   

0.028

 

0.003

Absent

73

52

50

 

2.801 (1.435-5.470)

 

Present

62

72

68

 

1.000

 

Type of radical resection

   

<0.001

  

Extended cholecystectomy

93

77

76

   

Major hepatectomy

19

9

9

   

Pancreaticoduodenectomy

15

45

28

   

Major hepatectomy with pancreaticoduodenectomy

8

25

25

   

Timing of radical resection

   

0.007

  

Initial radical resection

111

56

52

   

Radical second resection

24

86

86

   

Adjuvant chemotherapy

   

0.093

  

Absent

85

57

52

   

Present

50

68

68

   

Size of the primary tumor (mm)

   

0.869

  

≤60

68

61

59

   

>60

67

61

57

   

pT classification*

   

<0.001

 

0.005

pT1 plus pT2

80

87

85

 

1.000

 

pT3 plus pT4

55

21

15

 

3.145 (1.412-6.948)

 

Total lymph node count (TLNC)

   

0.102

  

≤16

76

66

66

   

>16

59

55

48

   

Location of positive lymph nodes*

   

<0.001

  

pN0

76

80

80

   

pN1

24

57

46

   

pN2

35

23

20

   

Number of positive lymph nodes

   

<0.001

 

0.004

0

76

80

80

 

1.000

 

1-3

39

51

41

 

1.640 (0.784-3.431)

 

≥4

20

10

10

 

4.997 (1.905-13.003)

 

Lymph node ratio (LNR; %)

   

<0.001

  

0

76

80

80

   

0-10

22

60

49

   

>10

37

24

20

   

pM classification*

   

<0.001

 

0.014

pM0

109

72

69

 

1.000

 

pM1

26†

13

7

 

2.260 (1.178-4.337)

 

Histological type*

   

<0.001

  

Adenocarcinoma

114

66

64

   

Others

21

32

26

   

Histological grade*

   

0.001

 

<0.001

G1 plus G2

96

68

67

 

1.000

 

G3 plus G4

39

42

34

 

3.472 (1.766-6.828)

 

Lymphatic vessel invasion (L)*

   

<0.001

  

L0

57

85

83

   

L1

78

44

41

   

Venous invasion (V)*

   

<0.001

 

0.007

V0

74

78

76

 

1.000

 

V1

61

41

37

 

2.445 (1.279-4.673)

 

Perineural invasion

   

<0.001

  

Absent

88

77

74

   

Present

47

29

26

   

Residual tumor status*

   

<0.001

 

0.003

R0

121

67

64

 

1.000

 

R1 plus R2

14

0

0

 

3.306 (1.519-7.195)

 
  1. *According to the AJCC cancer staging manual (7th edition)[8].
  2. †Includes 13 with paraaortic nodal disease.
  3. CI, confidence interval; pT classification, pathological primary tumor classification; pN classification, pathological regional lymph nodes classification; pM classification, pathological distant metastasis classification; G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; G4, undifferentiated; L0, no lymphatic vessel invasion; L1, lymphatic vessel invasion; V0, no venous invasion; V1, microscopic venous invasion; R0, no residual tumor; R1, microscopic residual tumor; R2, macroscopic residual tumor.